PathogenicLRRK2variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
Berwick, Daniel C., Javaheri, Behzad, Wetzel, Andrea, Hopkinson, Mark, Nixon-Abell, Jonathon, Grannò, Simone, Pitsillides, Andrew A., Harvey, KirstenVolume:
12
Language:
english
Journal:
Molecular Neurodegeneration
DOI:
10.1186/s13024-017-0153-4
Date:
December, 2017
File:
PDF, 1.49 MB
english, 2017